• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Simultaneous detection of tau phospho-epitopes with haptenylated antibodies
 
  • Details
  • Full
Options
2006
Journal Article
Title

Simultaneous detection of tau phospho-epitopes with haptenylated antibodies

Abstract
Neurofibrillary tangles as a neuropathological hallmark of Alzheimer's disease are mainly composed of abnormally phosphorylated microtubule-associated protein tau. The present work was primarily focused on the immunohistochemical characterization of recently developed monoclonal antibodies directed against disease-associated epitopes. Anti-phospho-threonine 212/phospho-serine 214 (HPT-1), anti-phospho-threonine 231/phospho-serine 235 (HPT-101) and their biotinylated derivatives were shown to be sensitive markers for the immunohistochemical detection of neuropathological alterations during Alzheimer's disease. Triple carbocyanine immunofluorescence labelling was based on digoxigenylated, fluoresceinated and biotinylated primary antibodies. AT8-immunolabelling of phospho-serine 202 and phospho-threonine 205 combined with HPT-1 and HPT-101-staining revealed similar distribution patterns of the three double-phosphorylated tau epitopes in the neocortex of patients with Alzheimer's disease.
Author(s)
Härtig, W.
Lehmann, J.
Stieler, J.
Singer, D.
Grosche, J.
Arendt, T.
Hoffmann, J.
Journal
Neuroreport  
DOI
10.1097/01.wnr.0000215778.76602.da
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Keyword(s)
  • Alzheimer's disease

  • anti-digoxin

  • anti-fluorescein

  • carbocyanine

  • digoxigenin-anti-digoxigenin

  • hapten-anti-hapten technique

  • neocortex

  • tau pathology

  • triple immunofluorescence labelling

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024